日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II trial of temsirolimus in patients with metastatic breast cancer.

替西罗莫司治疗转移性乳腺癌患者的 II 期试验

Fleming Gini F, Ma Cynthia X, Huo Dezheng, Sattar Husain, Tretiakova Maria, Lin L, Hahn Olwen M, Olopade F O, Nanda R, Hoffman Philip C, Naughton M J, Pluard Timothy, Conzen Suzanne D, Ellis Matthew J